![](/img/cover-not-exists.png)
Imatinib in Melanoma: A Selective Treatment Option Based on KIT Mutation Status?
Becker, J. C., Brocker, E. B., Schadendorf, D., Ugurel, S.Volume:
25
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2006.08.9664
Date:
January, 2007
File:
PDF, 43 KB
english, 2007